apixaban
Apixaban is a drug used to treat Atrial Fibrillation, Venous Thromboembolism, Pulmonary Embolism, and other conditions. Apixaban is being actively studied in 48 studies and prior, has been studied in 78.
Top Sponsors | Top Sites | Top Investigators |
---|---|---|
Bristol-Myers Squibb | Local Institution | Jeffrey Kline |
Pfizer | Duke University Medical Center | Jessica Franklin |
Bayer | Henry Ford Hospital | Scott C. Woller, MD |
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
A
Active, not recruiting
- Venous Thromboembolism
- Anticoagulants
- Apixaban
- Firenze, ItalyDaniela Poli
2022-03-10
Mar 10, 2022A
Recruiting
- Intrahepatic Non Cirrhotic Portal Hypertension
- Apixaban
- Placebo
- Clichy, FranceBeaujon hospital
2022-03-21
Mar 21, 2022S
Completed
- Left Ventricular Thrombus
- Apixaban
- Warfarin
- Dammam, Saudi ArabiaSaud AlBabtain Cardiac Center
2022-01-12
Jan 12, 2022B
Available
- Apixaban
- Philadelphia, PennsylvaniaChildrens Hospital Of Philadelphia
2022-03-07
Mar 7, 2022N
Recruiting
- Obesity, Morbid
- Apixaban
- Trondheim, NorwaySt. Olavs University Hospital
2022-03-14
Mar 14, 2022T
Completed
- Pancreas Cancer
- +2 more
- Apixaban
- Philadelphia, PennsylvaniaThomas Jefferson University Clinical Research Unit
2021-12-06
Dec 6, 2021P
Recruiting
- Heart Failure
- Apixaban
- +2 more
- Falls Church, VirginiaInova Fairfax Medical Campus
2022-02-21
Feb 21, 2022S
Not yet recruiting
- COVID-19
- Apixaban
- Rivaroxaban
- Rawalpindi, Punjab, PakistanRawalpindi Medical University
2022-02-22
Feb 22, 2022U
Terminated
- Anti-Xa Activity
- apixaban
- Vancouver, British Columbia, CanadaVancouver General Hospital
2021-07-28
Jul 28, 2021O
Recruiting
- Atrial Fibrillation
- Apixaban
- Rivaroxaban
- Ottawa, Ontario, CanadaThe Ottawa Hospital - General Campus
2022-03-14
Mar 14, 2022O
Completed
- Venous Thromboembolism
- Apixaban
- Rivaroxaban
- Edmonton, Alberta, Canada
- +3 more
2022-03-21
Mar 21, 2022I
Suspended
- Deep Venous Thrombosis
- +4 more
- apixaban
- Murray, UtahIntermountain Medical Center
2021-08-24
Aug 24, 2021A
Recruiting
- Venous Thromboembolism
- +2 more
- Abelacimab
- Apixaban
- Detroit, Michigan
- +1 more
2022-03-16
Mar 16, 2022U
Completed
- Transient Ischemic Attack
- +2 more
- Apixaban
- Warfarin
- Torrance, California
- +4 more
2021-11-03
Nov 3, 2021U
Completed
- Pharmacokinetics
- +2 more
- Apixaban
- Saskatoon, Saskatchewan, CanadaSaskatchewan Health Authority
2021-04-28
Apr 28, 2021J
Completed
- Bariatric Surgery
- Obesity
- Apixaban
- Baltimore, MarylandThe Johns Hopkins Center for Bariatric Surgery
2020-12-01
Dec 1, 2020A
Recruiting
- Atrial Fibrillation
- End-stage Kidney Disease
- Apixaban
- Phenprocoumon
- Münster, GermanyUniversitätsklinikum Münster
2021-04-26
Apr 26, 2021S
Active, not recruiting
- Antiphospholipid Syndrome
- Thrombosis
- Apixaban
- Warfarin
- Columbus, Ohio
- +1 more
2021-08-24
Aug 24, 2021M
Terminated
- Atrial Fibrillation
- Apixaban
- Warfarin
- Rochester, MinnesotaMayo Clinic in Rochester
2021-02-23
Feb 23, 2021M
Terminated
- Heparin-induced Thrombocytopenia
- Heparin-induced Thrombocytopenia and Thrombosis
- Apixaban
- Boston, Massachusetts
- +2 more
2020-11-29
Nov 29, 2020U
Completed
- Embolic Stroke of Undetermined Source
- Apixaban
- Aspirin
- Berlin, Germany
- +15 more
2021-10-12
Oct 12, 2021S
Completed
- Coronary Artery Bypass Grafting
- +4 more
- Apixaban
- Warfarin
- Fargo, North DakotaSanford Health
2020-12-28
Dec 28, 2020O
Recruiting
- Venous Thromboembolism
- Apixaban
- Rivaroxaban
- Calgary, Alberta, Canada
- +16 more
2022-03-14
Mar 14, 2022I
Recruiting
- LVAD (Left Ventricular Assist Device) Thrombosis
- HeartMate 3
- Apixaban
- Prague, CzechiaInstitute for Clinical and Experimental Medicine
2022-04-07
Apr 7, 2022M
Recruiting
- Cancer Patients
- +2 more
- Apixaban
- London, Ontario, Canada
- +1 more
2021-07-30
Jul 30, 2021